Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
2021 · World Journal of Surgical Oncology · 28 citations
https://doi.org/10.1186/s12957-021-02361-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
154
Citations
6
h-index
6
i10-index
Hüseyin Karatay is an academic researcher from University of Health Science. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Cells and Metastasis & Pituitary Gland Disorders and Treatments. The author has an h-index of 6, co-authored 28 publications.
ORCID: 0000-0002-4217-2834https://doi.org/10.1186/s12957-021-02361-9
https://doi.org/10.1007/s00423-025-03667-y
Click to start Chat